March 05, 2026 a 08:00 am
COO: Fundamental Ratio Analysis - The Cooper Companies, Inc.
The Cooper Companies, Inc. has shown stability with its diverse operations across two key segments: CooperVision and CooperSurgical. While the healthcare industry presents inherent challenges, the company’s ability to innovate in contact lens technology and women’s health care keeps it competitive. Their strong position in the global market offers potential for steady growth.
Fundamental Rating
The current fundamental scores reflect the company's stable financial standing with room for improvement in certain areas.
| Category | Score | Visualization |
|---|---|---|
| Overall | 3 | |
| Discounted Cash Flow | 3 | |
| Return on Equity | 3 | |
| Return on Assets | 4 | |
| Debt to Equity | 2 | |
| Price to Earnings | 1 | |
| Price to Book | 3 |
Historical Rating
The historical ratings provide a comparative perspective of the company's performance over time.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-03-04 | 3 | 3 | 3 | 4 | 2 | 1 | 3 |
| N/A | 0 | 3 | 2 | 3 | 1 | 0 | 0 |
Analyst Price Targets
Analyst targets suggest moderate optimism with a clear consensus on the stock's upward potential.
| High | Low | Median | Consensus |
|---|---|---|---|
| 100 | 73 | 98 | 93.86 |
Analyst Sentiment
The analyst sentiment shows a prevailing tendency to buy with minimal sell recommendations.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 15 | |
| Hold | 8 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
The Cooper Companies, Inc. presents a strong case for potential growth with stability in its core healthcare segments. However, certain financial metrics such as debt to equity may require improvement to enhance investor confidence. While always present in the healthcare field, risks are moderated by the company's strategic positioning and continuous innovation. Overall, The Cooper Companies provides a cautious yet promising investment opportunity, particularly for those focused on long-term growth within healthcare markets.